| Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily. E Gavriilaki, RA Brodsky British journal of haematology 189 (6), 2020 | 218 | 2020 |
| Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS S Chaturvedi, EM Braunstein, X Yuan, J Yu, A Alexander, H Chen, ... Blood, The Journal of the American Society of Hematology 135 (4), 239-251, 2020 | 182 | 2020 |
| Clinical significance of endothelial dysfunction in essential hypertension E Gkaliagkousi, E Gavriilaki, A Triantafyllou, S Douma Current hypertension reports 17, 1-9, 2015 | 147 | 2015 |
| Direct evidence of complement activation in HELLP syndrome: A link to atypical hemolytic uremic syndrome AJ Vaught, E Gavriilaki, N Hueppchen, K Blakemore, X Yuan, SM Seifert, ... Experimental hematology 44 (5), 390-398, 2016 | 111 | 2016 |
| Modified Ham test for atypical hemolytic uremic syndrome E Gavriilaki, X Yuan, Z Ye, AJ Ambinder, SP Shanbhag, MB Streiff, ... Blood, The Journal of the American Society of Hematology 125 (23), 3637-3646, 2015 | 111 | 2015 |
| Complement in thrombotic microangiopathies: unraveling Ariadne's thread into the labyrinth of complement therapeutics E Gavriilaki, A Anagnostopoulos, DC Mastellos Frontiers in immunology 10, 337, 2019 | 102 | 2019 |
| Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management E Gkaliagkousi, E Gavriilaki, M Doumas, K Petidis, S Aslanidis, D Stella JCR: Journal of Clinical Rheumatology 18 (8), 422-430, 2012 | 100 | 2012 |
| Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome X Yuan, E Gavriilaki, JA Thanassi, G Yang, AC Baines, SD Podos, ... Haematologica 102 (3), 466, 2017 | 95 | 2017 |
| Complementopathies and precision medicine E Gavriilaki, RA Brodsky The Journal of clinical investigation 130 (5), 2152-2163, 2020 | 86 | 2020 |
| Association between retinal vessel caliber and arterial stiffness in a population comprised of normotensive to early-stage hypertensive individuals A Triantafyllou, P Anyfanti, E Gavriilaki, X Zabulis, E Gkaliagkousi, ... American journal of hypertension 27 (12), 1472-1478, 2014 | 79 | 2014 |
| Transplant-associated thrombotic microangiopathy: opening Pandora’s box E Gavriilaki, I Sakellari, A Anagnostopoulos, RA Brodsky Bone marrow transplantation 52 (10), 1355-1360, 2017 | 71 | 2017 |
| Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients A Triantafyllou, P Anyfanti, X Zabulis, E Gavriilaki, P Karamaounas, ... Journal of the American Society of Hypertension 8 (8), 542-549, 2014 | 68 | 2014 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 66 | 2022 |
| Transplant‐associated thrombotic microangiopathy: incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation E Gavriilaki, I Sakellari, I Batsis, D Mallouri, Z Bousiou, A Vardi, E Yannaki, ... Clinical Transplantation 32 (9), e13371, 2018 | 61 | 2018 |
| Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension A Triantafyllou, M Doumas, P Anyfanti, E Gkaliagkousi, X Zabulis, ... American journal of hypertension 26 (3), 318-325, 2013 | 61 | 2013 |
| Genetic justification of severe COVID-19 using a rigorous algorithm E Gavriilaki, PG Asteris, T Touloumenidou, EE Koravou, M Koutra, ... Clinical Immunology 226, 108726, 2021 | 60 | 2021 |
| Increased erythrocyte-and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus E Gkaliagkousi, B Nikolaidou, E Gavriilaki, A Lazaridis, E Yiannaki, ... Diabetes and Vascular Disease Research 16 (5), 458-465, 2019 | 60 | 2019 |
| Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated P Anyfanti, E Gavriilaki, A Pyrpasopoulou, G Triantafyllou, A Triantafyllou, ... Clinical rheumatology 35, 733-739, 2016 | 58 | 2016 |
| Linking complement activation, coagulation, and neutrophils in transplant-associated thrombotic microangiopathy E Gavriilaki, A Chrysanthopoulou, I Sakellari, I Batsis, D Mallouri, ... Thrombosis and haemostasis 119 (09), 1433-1440, 2019 | 57 | 2019 |
| Genetic prediction of ICU hospitalization and mortality in COVID‐19 patients using artificial neural networks PG Asteris, E Gavriilaki, T Touloumenidou, EE Koravou, M Koutra, ... Journal of cellular and molecular medicine 26 (5), 1445-1455, 2022 | 56 | 2022 |
STELLA DOUMA, S DOUMAS, STELL...ASS PROF INTERNAL MEDICINE, UNIVERSITY OF THESSALONIKI在 med.auth.gr 的电子邮件经过验证
